StockWatch: Amgen Throws Its Weight Behind Obesity Drug
Amgen chairman and CEO Robert A. Bradway Amgen (AMGN) signaled it intends to become the third powerhouse developer in the booming weight loss drug segment on Thursday, as two of its top executives delivered positive comments about the progress of its …